DrugPatentWatch Database Preview
Drugs in Development Information for ADL5859
» See Plans and Pricing
What is the development status for investigational drug ADL5859?
ADL5859 is an investigational drug.
There have been 4 clinical trials for ADL5859.
The most recent clinical trial was a Phase 2 trial, which was initiated on November 1st 2007.
The most common disease conditions in clinical trials are Arthritis, Peripheral Nervous System Diseases, and Neuralgia. The leading clinical trial sponsors are Cubist Pharmaceuticals LLC, Pfizer, and [disabled in preview].
Summary for ADL5859
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 15 |
| WIPO Patent Applications | 4 |
| Japanese Patent Applications | 1 |
| Clinical Trial Progress | Phase 2 (2007-11-01) |
| Vendors | 17 |
Recent Clinical Trials for ADL5859
| Title | Sponsor | Phase |
|---|---|---|
| Efficacy and Safety Study Evaluating ADL5859 and ADL5747 in Participants With Pain Due to Osteoarthritis of the Knee | Pfizer | Phase 2 |
| Efficacy and Safety Study Evaluating ADL5859 and ADL5747 in Participants With Pain Due to Osteoarthritis of the Knee | Cubist Pharmaceuticals LLC | Phase 2 |
| Safety and Efficacy Study of ADL5859 in Participants With Neuropathic Pain Associated With Diabetic Peripheral Neuropathy | Cubist Pharmaceuticals LLC | Phase 2 |
Clinical Trial Summary for ADL5859
Top disease conditions for ADL5859
Top clinical trial sponsors for ADL5859
US Patents for ADL5859
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
